Stimulation of bone formation by zoledronic acid in particle-induced osteolysis

Biomaterials

Volumn 26, Issue 17, 2005, Pages 3719-3725

  Wedemeyer, Christian ^a   Von Knoch, Fabian ^b   Pingsmann, Andreas ^a   Hilken, Gero ^a   Sprecher, Christoph ^c   Saxler, Guido ^a   Henschke, Frank ^d   Löer, Franz ^a   Von Knoch, Marius ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b KANTONSSPITAL   (Switzerland)

^c AO RESEARCH INSTITUTE   (Switzerland)

^d Pathologisches Inst Am J   (Germany)

Author keywords

Histomorphometry; Net bone growth; Polyethylene particles; Wear debris; Zoledronic acid

Indexed keywords

BONE APPOSITION; OSTEOLYSIS; PARTICLE IMPLANTATION; ZOLEDRONIC ACID;

IMPLANTS (SURGICAL); MATHEMATICAL MODELS; ORGANIC ACIDS; POLYETHYLENES; STATISTICAL METHODS; SURGERY;

BONE;

DYE; POLYETHYLENE; ZOLEDRONIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE GROWTH; BONE TISSUE; CONTROLLED STUDY; DRUG EFFECT; GIEMSA STAIN; IMPLANTATION; MOUSE; NONHUMAN; OSSIFICATION; OSTEOLYSIS; PARTICULATE MATTER; PRIORITY JOURNAL; SINGLE DRUG DOSE; STATISTICAL ANALYSIS; STUDENT T TEST; THICKNESS;

ANIMALS; DIPHOSPHONATES; FOREIGN-BODY REACTION; IMIDAZOLES; MICE; MICE, INBRED C57BL; OSTEOGENESIS; OSTEOLYSIS; PARTICLE SIZE; POLYETHYLENES; PROSTHESIS FAILURE; PROSTHESIS-RELATED INFECTIONS; SKULL; TREATMENT OUTCOME;

ANIMALIA; MURINAE;

EID: 11144290571     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2004.09.026     Document Type: Article

References (29)

1. H.G. Willert, H. Bertram, and G.H. Buchhorn Osteolysis in alloarthroplasty of the hip. The role of ultra-high molecular weight polyethylene wear particles Clin Orthop 258 1990 95 107
2. M. von Knoch, D.E. Jewison, J.D. Sibonga, C. Sprecher, B.F. Morrey, F. Loer, D.J. Berry, and S.P. Scully The effectiveness of polyethylene versus titanium particles in inducing osteolysis in vivo J Orthop Res 22 2 2004 237 243
3. M.J. Silva, and L.J. Sandell What's New in Orthopaedic Research J Bone Joint Surg Am 84-A 8 2002 1490 1496
4. P.K. Venesmaa Alendronate reduces periprosthetic bone loss after uncemented primary total hip arthroplasty a prospective randomized study J Bone Miner Res 16 2001 2126 2131
5. A.S. Shanbhag, C.T. Hasselman, and H.E. Rubash The John Charnley Award Inhibition of wear debris mediated osteolysis in a canine total hip arthroplasty model. Clin Orthop 344 1997 33 43
6. P.J. Millett, M.J. Allen, and M.P. Bostrom Effects of alendronate on particle-induced osteolysis in a rat model J Bone Joint Surg Am 84-A 2 2002 236 249
7. E.M. Schwarz, A.P. Lu, J.J. Goater, E.B. Benz, G. Kollias, R.N. Rosier, J.E. Puzas, and R.J. O'Keefe Tumor necrosis factor-alpha/nuclear transcription factor-kappaB signaling in periprosthetic osteolysis J Orthop Res 18 3 2000 472 480
8. S.M. Cheer, and S. Noble Zoledronic acid Drugs 61 6 2001 799 805
9. I.R. Reid, J.P. Brown, P. Burckhardt, Z. Horowitz, P. Richardson, U. Trechsel, A. Widmer, J.P. Devogelaer, J.M. Kaufman, P. Jaeger, J.J. Body, M.L. Brandi, J. Broell, R. Di Micco, A.R. Genazzani, D. Felsenberg, J. Happ, M.J. Hooper, J. Ittner, G. Leb, H. Mallmin, T. Murray, S. Ortolani, A. Rubinacci, M. Saaf, G. Samsioe, L. Verbruggen, and P.J. Meunier Intravenous zoledronic acid in postmenopausal women with low bone mineral density N Engl J Med 346 9 2002 653 661
10. L.I. Plotkin, R.S. Weinstein, A.M. Parfitt, P.K. Roberson, S.C. Manolagas, and T. Bellido Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin J Clin Invest 104 1999 1363 1374
11. G.G. Reinholz, B. Getz, L. Pederson, E.S. Sanders, M. Subramaniam, J.N. Ingle, and T.C. Spelsberg Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts Cancer Res 60 2000 6001 6007
12. G.I. Im, S.A. Qureshi, J. Kenney, H.E. Rubash, and A.S. Shanbhag Osteoblast proliferation and maturation by bisphosphonates Biomaterials 25 18 2004 4105 4115
13. F. von Knoch, M. Kowalsky, L. Weissbach, G. Im, B. Puskas, F. Fishman, H.E. Rubash, and A.S. Shanbag Bisphosphonates enhance osteoblastic recruitment from human bone marrow stromal cells in vitro Trans ORS 873 2003
14. J.R. Green, K. Müller, and K.A. Jaeggi Preclinical pharmacology of CGP 42′446, a potent, heterocyclic bisphosphonate compound J Bone Miner Res 9 1994 745 751
15. A.S. Shanbhag, D. May, C. Cha, C. Kovach, C.T. Hasselmann, and H.E. Rubash Enhancing net bone formation in canine total hip components with bisphosphonates Trans ORS 93 1999
16. D.G. Little, N.C. Smith, P.R. Williams, J.N. Briody, L.E. Bilston, E.J. Smith, E.M. Gardiner, and C.T. Cowell Zoledronic acid prevents osteopenia and increases bone strength in a rabbit model of distraction osteogenesis J Bone Miner Res 18 2003 1300 1307
17. von Knoch F, Cho MR, Garrigues G, Kowalsky M, Rubash HE, Shanbag AS. Effects of bisphosphonates (alendronate and zolendronate) on bone ingrowth in a rabbit model: a radiographic and histomorphometric analysis. Trans ORS 2003;1375.
18. B. Pan, L.B. To, A.N. Farrugia, D.M. Findlay, J. Green, S. Gronthos, A. Evdokin, K. Lynch, G.J. Atkins, and A.C. Zannettino The nitrogen-containing bisphosphonate, zoledronic acid, increases mineralisation of human bone-derived cells in vitro Bone 34 1 2004 112 123
19. B. Pan, A.N. Farrugia, L.B. To, D.M. Findlay, J. Green, K. Lynch, and A.C. Zannettino Nitrogen-containing bisphosphonate, zoledronic acid, influences RANKL expression in human osteoblast-like cells by activating TNF-alpha converting enzyme (TACE) J Bone Miner Res 19 1 2004 147 154
20. von Knoch M, Wedemeyer C, Pingsmann A, von Knoch F, Hilken G, Sprecher C, Henschke F, Barden B, Löer F. The decrease of particle-induced osteolysis after a single dose of bisphosphonate. Biomaterials 2004, in press. doi:10.1016/j.biomaterials.2004.06.010
21. M. von Knoch, C. Sprecher, B. Barden, G. Saxler, F. Loer, and M. Wimmer Size and shape of commercially available polyethylene particles for in-vitro and in-vivo-experiments Z Orthop Ihre Grenzgeb 142 3 2004 366 370
22. M.J. Baer Patterns of growth of the skull as revealed by vital staining Hum Biol 26 1954 80 126
23. L.J. Baume Principles of cephalofacial development revealed by experimental biology Am J Orthodont 47 1961 881 901
24. D.H. Enlow Normal craniofacial growth M.M.J. Cohen R.E. Mac-Lean Craniosynostosis diagnosis, evaluation and management, second ed 2000 Oxford University Press New York 35 50
25. J.J. Pritchard, J.H. Scott, and F.G. Girgis The structure and development of cranial and facial sutures J Anat 90 1956 73 86
26. L.A. Opperman, A. Chhabra, A.A. Nolen, Y. Bao, and R.C. Ogle Dura mater maintains rat cranial sutures in vitro by regulating suture cell proliferation and collagen production J Craniofac Genet Dev Biol 18 1998 150 158
27. S.C. Manolagas Birth and death of bone cells. Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis Endocr Rev 21 2000 115 137
28. G.F. Couly, P.M. Coltey, and N.M. Le Douarin The development fate of the cephalic mesoderm in quail-chick chimeras Development 114 1992 1 15
29. G.F. Couly, P.M. Coltey, and N.M. Le Douarin The triple origin of skull in higher vertebrates a study in quail-chick chimeras Development 117 1993 409 429